Amgen is a pioneer in the science of using living cells to make biologic medicines.

Feature A Strategy for Making Clinical Trials More Successful In a bid to make clinical trials faster, less costly, and more successful, Amgen is making adaptive trial designs its default setting for clinical research.
Feature Amgen's First-in-Class Science Feature The New Genetics: Inside Amgen's Human Genome Experiment Feature How Real-World Data is Transforming Drug Development Feature Protein Engineering: Unlocking the Power of Proteins Feature The Passionate Pursuit of Nav 1.7 Feature Amgen’s Growing Immunotherapy Arsenal Feature The Next Generation of Biotech Manufacturing

The Shape of Drugs to Come

Biotechnology opened the door to new types of medicines based on nature’s own building blocks. No company has done more to advance this revolution than Amgen, and the company’s broad toolkit of drug modalities just got larger.

Feature A Gene Linked to Lower Risks of Heart Attacks Feature Better Science Through Biosimilar R&D Feature Genetic Insights Fuel Alzheimer's BACE Race

Subscribe for the latest from Amgen Science.

System error message. Lorem ipsum.
I authorize Amgen and its contractors to use my email address and provide me with updates, informational material, and/or contact me about Amgen Science. I understand that my email address will not be used for any other purposes. I understand that receiving these communications is optional and free and that I have the ability to opt out at anytime. For more information, please see the Amgen privacy policy.